Fig. 4From: The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic miceThe effects of MSC injection on liver fat content and serum lipid profiles. A, B Representative images of Oil Red O-stained liver sections of the indicated groups. Scale bar = 50 μm. The red lipid staining were used for statistics. db/db mice were injected with human UC-MSCs, PU-MSCs, AD-MSCs, or PBS every 2 weeks for 6 weeks. MET, metformin. After the last injections, serum concentrations of C TC, D TG, E HDL-C, and F LDL-C in the indicated groups were measured. The results are expressed as the means ± S.E.M. n = 6 mice per group. *P<0.05, **P<0.01, ***P<0.001 versus the vehicle group. One-way ANOVABack to article page